BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31822496)

  • 1. ARRB1-Promoted NOTCH1 Degradation Is Suppressed by OncomiR miR-223 in T-cell Acute Lymphoblastic Leukemia.
    Shu Y; Wang Y; Lv WQ; Peng DY; Li J; Zhang H; Jiang GJ; Yang BJ; Liu S; Zhang J; Chen YH; Tang S; Wan KX; Yuan JT; Guo W; Fu G; Qi XK; Liu ZD; Liu HY; Yang C; Zhang LH; Liu FJ; Yu J; Zhang PH; Qu B; Zhao H; He TC; Zou L
    Cancer Res; 2020 Mar; 80(5):988-998. PubMed ID: 31822496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.
    Marchesini M; Gherli A; Montanaro A; Patrizi L; Sorrentino C; Pagliaro L; Rompietti C; Kitara S; Heit S; Olesen CE; Møller JV; Savi M; Bocchi L; Vilella R; Rizzi F; Baglione M; Rastelli G; Loiacono C; La Starza R; Mecucci C; Stegmaier K; Aversa F; Stilli D; Lund Winther AM; Sportoletti P; Bublitz M; Dalby-Brown W; Roti G
    Cell Chem Biol; 2020 Jun; 27(6):678-697.e13. PubMed ID: 32386594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia.
    Gianni F; Belver L; Ferrando A
    Cold Spring Harb Perspect Med; 2020 Mar; 10(3):. PubMed ID: 31570389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia.
    Baran N; Lodi A; Dhungana Y; Herbrich S; Collins M; Sweeney S; Pandey R; Skwarska A; Patel S; Tremblay M; Kuruvilla VM; Cavazos A; Kaplan M; Warmoes MO; Veiga DT; Furudate K; Rojas-Sutterin S; Haman A; Gareau Y; Marinier A; Ma H; Harutyunyan K; Daher M; Garcia LM; Al-Atrash G; Piya S; Ruvolo V; Yang W; Shanmugavelandy SS; Feng N; Gay J; Du D; Yang JJ; Hoff FW; Kaminski M; Tomczak K; Eric Davis R; Herranz D; Ferrando A; Jabbour EJ; Emilia Di Francesco M; Teachey DT; Horton TM; Kornblau S; Rezvani K; Sauvageau G; Gagea M; Andreeff M; Takahashi K; Marszalek JR; Lorenzi PL; Yu J; Tiziani S; Hoang T; Konopleva M
    Nat Commun; 2022 May; 13(1):2801. PubMed ID: 35589701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mouse model for inducible overexpression of Prdm14 results in rapid-onset and highly penetrant T-cell acute lymphoblastic leukemia (T-ALL).
    Carofino BL; Ayanga B; Justice MJ
    Dis Model Mech; 2013 Nov; 6(6):1494-506. PubMed ID: 24046360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOTCH1-driven UBR7 stimulates nucleotide biosynthesis to promote T cell acute lymphoblastic leukemia.
    Srivastava S; Sahu U; Zhou Y; Hogan AK; Sathyan KM; Bodner J; Huang J; Wong KA; Khalatyan N; Savas JN; Ntziachristos P; Ben-Sahra I; Foltz DR
    Sci Adv; 2021 Jan; 7(5):. PubMed ID: 33571115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory mechanisms and context-dependent roles of TAL1 in T-cell acute lymphoblastic leukemia.
    Ong JZL; Tan TK; Wang L; Tan SH; Sanda T
    Haematologica; 2024 May; 109(5):1359-1372. PubMed ID: 37855064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL).
    Shaw TI; Dong L; Tian L; Qian C; Liu Y; Ju B; High A; Kavdia K; Pagala VR; Shaner B; Pei D; Easton J; Janke LJ; Porter SN; Ma X; Cheng C; Pruett-Miller SM; Choi J; Yu J; Peng J; Gu W; Look AT; Downing JR; Zhang J
    Sci Rep; 2021 Mar; 11(1):5154. PubMed ID: 33664368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia.
    Sanghvi VR; Mavrakis KJ; Van der Meulen J; Boice M; Wolfe AL; Carty M; Mohan P; Rondou P; Socci ND; Benoit Y; Taghon T; Van Vlierberghe P; Leslie CS; Speleman F; Wendel HG
    Sci Signal; 2014 Nov; 7(352):ra111. PubMed ID: 25406379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Simplified System to Express Circularized Inhibitors of miRNA for Stable and Potent Suppression of miRNA Functions.
    Shu Y; Wu K; Zeng Z; Huang S; Ji X; Yuan C; Zhang L; Liu W; Huang B; Feng Y; Zhang B; Dai Z; Shen Y; Luo W; Wang X; Liu B; Lei Y; Ye Z; Zhao L; Cao D; Yang L; Chen X; Luu HH; Reid RR; Wolf JM; Lee MJ; He TC
    Mol Ther Nucleic Acids; 2018 Dec; 13():556-567. PubMed ID: 30414569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA-NEAT1 promotes proliferation of T-ALL cells via miR-146b-5p/NOTCH1 signaling pathway.
    Luo YY; Wang ZH; Yu Q; Yuan LL; Peng HL; Xu YX
    Pathol Res Pract; 2020 Nov; 216(11):153212. PubMed ID: 33010698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells as a potential therapy for COVID-19.
    Liu S; Peng D; Qiu H; Yang K; Fu Z; Zou L
    Stem Cell Res Ther; 2020 May; 11(1):169. PubMed ID: 32366290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR‑379‑5p inhibits cell proliferation and promotes cell apoptosis in non‑small cell lung cancer by targeting β‑arrestin‑1.
    Jiang Y; Zhu P; Gao Y; Wang A
    Mol Med Rep; 2020 Dec; 22(6):4499-4508. PubMed ID: 33173959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA SNHG5 regulates chemotherapy resistance through the miR-32/DNAJB9 axis in acute myeloid leukemia.
    Wang D; Zeng T; Lin Z; Yan L; Wang F; Tang L; Wang L; Tang D; Chen P; Yang M
    Biomed Pharmacother; 2020 Mar; 123():109802. PubMed ID: 31884339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-582-3p negatively regulates cell proliferation and cell cycle progression in acute myeloid leukemia by targeting cyclin B2.
    Li H; Tian X; Wang P; Huang M; Xu R; Nie T
    Cell Mol Biol Lett; 2019; 24():66. PubMed ID: 31844417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chinese expert brief consensus on newborn screening of inherited metabolic disorders during the novel coronavirus infection epidemic.
    Liu S; Wang D; Wan K; Liu H; Zhang D; Yang J; Yuan Z; He X; Wang J; Ou M; Zhu W; Qu Y; Zhao D; Wang W; Liu S; Gu M; Huang S; Wang Z; Zou L
    Ann Transl Med; 2020 Apr; 8(7):429. PubMed ID: 32395473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia.
    Saccomani V; Grassi A; Piovan E; Bongiovanni D; Di Martino L; Minuzzo S; Tosello V; Zanovello P
    Cells; 2020 Jul; 9(7):. PubMed ID: 32708470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hsa-miR-20b-5p and hsa-miR-363-3p Affect Expression of
    Drobna M; Szarzyńska B; Jaksik R; Sędek Ł; Kuchmiy A; Taghon T; Van Vlierberghe P; Szczepański T; Witt M; Dawidowska M
    Cells; 2020 May; 9(5):. PubMed ID: 32380791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circRNA_0000094 sponges microRNA-223-3p and up-regulate F-box and WD repeat domain containing 7 to restrain T cell acute lymphoblastic leukemia progression.
    Hou Y; Sun J; Huang J; Yao F; Chen X; Zhu B; Zhao D
    Hum Cell; 2021 May; 34(3):977-989. PubMed ID: 33677796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale circular RNA deregulation in T-ALL: unlocking unique ectopic expression of molecular subtypes.
    Buratin A; Paganin M; Gaffo E; Dal Molin A; Roels J; Germano G; Siddi MT; Serafin V; De Decker M; Gachet S; Durinck K; Speleman F; Taghon T; Te Kronnie G; Van Vlierberghe P; Bortoluzzi S
    Blood Adv; 2020 Dec; 4(23):5902-5914. PubMed ID: 33259601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.